Loyal

Other Pharmaceuticals and Biotechnology · San Francisco, CA · Founded 2019 · Privately Held (backing)

Developer of veterinary drugs designed to improve dogs' health span and lifespan. Loyal is based in San Francisco, CA and was founded in 2019. It was valued at $430 million at its later-stage round in Feb 2025, the last priced event on record. It has raised $236 million across 1 recorded round; the latest was a $27.7 million Series A in Sep 2021.

PMV mark · valuation
$430.0M
Oct 2026
Priced at
its later-stage round
Feb 2025
Total raised
$236.5M
Last round
Early Stage VC (Series A)
Sep 2021
How much has Loyal raised?
$236.5Macross 1 recorded rounds · Sep 2021 – Sep 2021

Most recently, Loyal raised $27.7M in its Early Stage VC (Series A) (Sep 2021).

Free account
More of Loyal with a free account
  • ·The complete investor list: 42 names
  • ·Watch Loyal: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Loyal round by round

1 rounds
Sep 2021Early Stage VC (Series A)$27.7M▮
+ 1 more investors · free account

How much has Loyal raised?

Loyal has raised $236 million in total; 1 of its rounds is on record. The largest on record was a $27.7 million Series A in Sep 2021.

Loyal investors

42 investors are on record for Loyal, including Khosla Ventures, Gaingels, Metaplanet Holdings and BoxGroup. By type, the record holds 12 venture capital firms and 2 growth equity firms. The Series A in Sep 2021 drew 9 investors.

For fundraisers
Raising for a company like Loyal?

42 investors have backed Loyal — start your target list with the firms already writing checks in other pharmaceuticals and biotechnology.

See all 42 investors →

Frequently asked about Loyal

How much has Loyal raised?
Loyal has raised $236.5M in total across 1 recorded funding rounds.
When was Loyal's last funding round?
Loyal's most recent recorded round was Early Stage VC (Series A) in Sep 2021, raising $27.7M.